Alembic Pharmaceuticals LimitedNSE: APLLTD

Alembic Pharmaceuticals Limited Press Release Jul 18 2026

Jul 18, 2026 at 11:05 AM EDT · Issued by Alembic Pharmaceuticals Limited via NSE India

Filed with NSE · Jul 18, 2026 at 11:05 AM EDT · 2 pages · English

On 6ix: 6ix.com/news/alembic-pharmaceuticals-limited-press-release-jul-18-2026

Release

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 18, 2026, titled "Alembic Pharmaceuticals Limited's Partner NATCO Pharma Limited receives USFDA Tentative Approval for Olaparib Tablets, 100 mg and 150 mg".

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Alembic Pharmaceuticals Limited Press Release Jun 26 2026Jun 26
Alembic Pharmaceuticals Limited Press Release Jun 19 2026Jun 19
Alembic Pharmaceuticals Limited Press Release Jun 12 2026Jun 12
Alembic Pharmaceuticals Limited Press Release Jun 11 2026Jun 11
Press Release Jun 05 2026Jun 5

Later from Alembic Pharmaceuticals

Alembic Pharmaceuticals Limited Press Release Jul 28 2026Jul 28
Alembic Pharmaceuticals Limited Press Release Aug 04 2026Aug 4
Alembic Pharmaceuticals Limited receives USFDA Final Approval for Ciprofloxacin and Dexamethasone Otic Suspension USP, 0.3% / 0.1%.Oct 17
Alembic Pharmaceuticals Limited receives USFDA Final Approval for Valganciclovir for Oral Solution, 50 mg/mL.Oct 27
Alembic Pharmaceuticals Limited receives USFDA Final Approval for Venetoclax Tablets, 10 mg, 50 mg and 100 mg.Oct 30

All Alembic Pharmaceuticals news releases

Follow Alembic Pharmaceuticals into a list and get an email when it puts out news.

Follow Alembic Pharmaceuticals